Founded
Address
Burrill & Co LLC
One Embarcadero Center
Suite 2700
San Francisco, CA 94111
United States
Phone
Website
Recent investment activity
KANDO id: 2488
Company type
Diversified global financial services firm focused on the life sciences industryFunds managed
Fund | Type | Vintage | Currency | Committed capital |
---|---|---|---|---|
Burrill Life Sciences Capital Fund IV | 2011 | USD | 500,000,000 |
Funding rounds
Investment preferences
Investment activity status
Not investing
Selected investments
Displaying 1 - 25 of 33Company | Profile | Country | Date Sort ascending | Funding | ||
---|---|---|---|---|---|---|
Strand Life Sciences Pvt Ltd | Series B | |||||
Ceptaris Therapeutics Inc | Specialty pharmaceuticals company. | Series D | ||||
WaveTec Vision Systems Inc | Venture Initial investment | |||||
Endocyte Inc | Folate-based cancer and autoimmune disease therapies | Series C | ||||
Aerovance Inc | N/A | |||||
Catalyst Biosciences Inc | Developer of catalytic biopharmaceutical products based on engineered human proteases. | Series C | ||||
Arete Therapeutics Inc | A biotechnology company, engages in the discovery and development of drugs to treat diabetes, and inflammatory and cardiovascular diseases. | Series A | ||||
Osprey Pharmaceuticals USA | Series A | |||||
Light Sciences Oncology Inc | Drug-device cancer therapy | Series B | ||||
Aerovance Inc | Series C | |||||
diaDexus Inc | Biotechnology company focused on the discovery, development & commercialization of novel, patent protected diagnostic product with high clinical value | Series E | ||||
Neurotech Pharmaceuticals Inc (Neurotech Inc) | Cell-based drugs for diseases of the eye. | Series B | ||||
Sciona Inc | Provides gene-based personalized health and nutrition analysis and recommendations based on individual diet, lifestyle, and genetic profile. | Series C | ||||
Catalyst Biosciences Inc | Developer of catalytic biopharmaceutical products based on engineered human proteases. | Series B | ||||
XDx Inc | N/A Initial investment | |||||
Adlyfe | Series A | |||||
Catalyst Biosciences Inc | Developer of catalytic biopharmaceutical products based on engineered human proteases. | Series A | ||||
Sciona Inc | Provides gene-based personalized health and nutrition analysis and recommendations based on individual diet, lifestyle, and genetic profile. | Series B | ||||
Logical Therapeutics Inc | An early stage biotechnology company | N/A | ||||
Immunicon Corp | Biotechnology company specializing in cell-based research and diagnostic products with an initial focus on cancer. | N/A | ||||
elbion AG | N/A | |||||
Whiteglove House Call Health Inc | N/A | |||||
Inhibitex Inc | N/A | |||||
AgraQuest Inc | Discovery, development, manufacturing and marketing of biopesticides and low-chem pest and disease control, and yield enhancing products. | N/A | ||||
ProteoGenix Inc | N/A |
Pagination
Current team
Former team members
Employee | Company | Position | ||
---|---|---|---|---|
Dr John E Hamer | Golden Pine Ventures LLC |